Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01107028 · ClinicalTrials.gov registry record
Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
A clinical trial, sponsored by National Jewish Health.
- Completed
- Registry status
- 41
- Enrollment target
NCT01107028 is a clinical trial that has completed, run by National Jewish Health. The registered enrollment target is 41 participants.
The verdict
NCT01107028 has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
Idiopathic pulmonary fibrosis (IPF) is a devastating disease marked by progressive lung scarring leading to multiple life-altering sequelae. The over-arching goals of the principal investigator's research program are to more fully characterize these sequelae and to examine interventions that might improve them. The hypotheses of this particular study are that pulmonary rehabilitation (PR) is one such intervention, and that PR will improve the sequelae of dyspnea and impairments in functional capacity, cognition, mood and anxiety, fatigue, and quality of life (QOL) in patients with IPF.
Interventions
- OTHER Standard pulmonary rehabilitation program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2010-02 |
| Est. Completion | 2014-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01107028
The ClinicalTrials.gov registry entry for NCT01107028 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Standard pulmonary rehabilitation program is the first listed.
NCT01107028 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01107028 about?
NCT01107028 is a clinical study titled "Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis". Idiopathic pulmonary fibrosis (IPF) is a devastating disease marked by progressive lung scarring leading to multiple life-altering sequelae. The over-arching goals of the principal investigator's research program are to more fully characterize these sequelae and to examine interventions that might i...
What is the current status of trial NCT01107028?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2010-02. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01107028?
The interventions under investigation include: Standard pulmonary rehabilitation program (OTHER).
Who is sponsoring clinical trial NCT01107028?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.